OTTAWA, Aug 13 (Reuters) - The Canadian authorities stated on Friday (Aug thirteen) it had signed an agreement with Moderna Inc for added deliver of its COVID-19 vaccine for 2022 and 2023, with an option to enlarge into 2024.
Canada will get hold of forty million doses, as in line with the deal, with an alternative for a further sixty five million doses. The agreement will allow get right of entry to to new COVID-19 vaccine variations.
The partnership "will help to bridge Canada's capability to hold a reliable and rapidly to be had deliver of vaccines into 2022 and 2023 in advance of Moderna's Canadian vaccine facility becoming operational", Procurement Minister Anita Anand said in a statement.
Earlier this week, Moderna signed a Memorandum of Understanding with the Canadian authorities, beneath which the vaccine maker will installation an mRNA vaccine manufacturing facility in Canada and also supply get admission to to its mRNA improvement engine.
No comments:
Post a Comment